›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:Archer® FusionPlex® Oncology Research Kit
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Integrated DNA TechnologiesType:
Laboratory Developed Test
Related tests:
The Archer® FusionPlex® Oncology Research Kit is a targeted next generation sequencing (NGS) assay to simultaneously detect and identify fusions and other mutations associated with 74 genes found in RNA transcripts that are linked to various cancers. This kit is extensive and purpose-built to advance fusion discovery, including research efforts in the area of Ph-like ALL fusions. Archer Analysis software allows the analysis and interpretation of the data.
Cancer:
Solid Tumor
Gene:
ABL1 (ABL proto-oncogene 1), ABL2 (ABL Proto-Oncogene 2, Non-Receptor Tyrosine Kinase), AKT1 (V-akt murine thymoma viral oncogene homolog 1), AKT2 (V-akt murine thymoma viral oncogene homolog 2), AKT3 (V-akt murine thymoma viral oncogene homolog 3), ALK (Anaplastic lymphoma kinase)
See More ...
ABL1 (ABL proto-oncogene 1), ABL2 (ABL Proto-Oncogene 2, Non-Receptor Tyrosine Kinase), AKT1 (V-akt murine thymoma viral oncogene homolog 1), AKT2 (V-akt murine thymoma viral oncogene homolog 2), AKT3 (V-akt murine thymoma viral oncogene homolog 3), ALK (Anaplastic lymphoma kinase), AXL (AXL Receptor Tyrosine Kinase), BRAF (B-raf proto-oncogene), ERBB3 (V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3), ETV5 (ETS Variant Transcription Factor 5), FGFR1 (Fibroblast growth factor receptor 1), FGFR2 (Fibroblast growth factor receptor 2), HER-2 (Human epidermal growth factor receptor 2), JAK1 (Janus Kinase 1), KIT (KIT proto-oncogene, receptor tyrosine kinase)
Method:
Next-Generation Sequencing (NGS)